Wim van den Brink (1952) received his medical degree in 1981 from the Free University in Amsterdam. After his psychiatric residency in Groningen (1981-1986), he was a fellow at the Psychiatric Epidemiology Training program at Columbia University in New York. In 1989 he received his PhD degree form the State University of Groningen, the Netherlands. Since 1992 he is full professor of Psychiatry and Addiction at the Academic Medical Center of the University of Amsterdam. He is also the director of the Amsterdam Institute for Addiction Research (AIAR). In 2014 he received the life time achievement award for science from the Netherlands Association of Psychiatry and in 2015 he was granted the status of honorable member of the Spanish Society for Dual disorders. He is a (co)author of more than 500 peer reviewed scientific papers and has been a thesis advisor of more than 60 PhD students. He is currently one of the chief-editors of European Addiction Research. He is the chair of the Workgroups that developed the Dutch Interdisciplinary Treatment Guideline on Alcohol Use Disorders and the Dutch Interdisciplinary Guideline on Opiate Addiction. He is one of the founders and the president of the International Collaboration of ADHD and Substance Abuse (ICASA). Until September 2015 he was the chair of the Scientific Program Committee of the European College of Neuropsychopharmacology (ECNP). His main scientific interest are related to the neurobiology of substance use disorders and behavioral addictions, the pharmacological treatment of addiction and related comorbidities, and the reduction of stigma regarding substance use and patients with an addiction.